Nathan O’Neill was terminated from the Health Net Pro Cycling Team Presented by Maxxis following confirmation of a positive test for the prescription appetite suppressant Phentermine.

The team was informed on September 24 that O’Neill’s A sample returned the positive result in a test performed on August 12, following the Tour of Elk Grove. His B sample confirmed the positive result in a test performed on October 24. The team terminated his contract immediately upon notification of the positive B sample on October 29.

According to UCI/WADA code, riders can legally use Phentermine out of competition with a prescription. However, there may be no trace amounts of Phentermine in a rider’s system during competition.

The Team has a zero tolerance policy regarding the failure of any of its riders to pass a UCI/WADA-sanctioned medical examination, which is grounds for immediate termination in accordance with the Team’s standard Rider Agreement, which all riders have signed.

Nathan has been a valuable member of the Team and has achieved many exceptional results. Nonetheless, it is the Team’s policy to treat all riders fairly and consistently, and by the terms of our Rider Agreement.

O’Neill obtained the medication legally. However, he did not follow proper team protocol concerning the use of prescription drugs obtained, directed to be obtained or approved by the Team’s Medical Director.

We wish him and his family the very best in the future. At present, this is now a personal matter between Nathan and UCI/WADA, and the team will not comment on it any further.